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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Coinfection of Mycoplasma pneumoniae is not uncommon in children
with respiratory syndromes. The purpose of this study was to investigate the impact of bacte-
rial and viral coinfection on mycoplasmal pneumonia in hospitalized children with community-
acquired pneumonia (CAP).
Methods: Children coinfected with M. pneumoniae in a prospective study of the etiology of
CAP at a tertiary pediatric facility Children’s Hospital were enrolled and retrospectively re-
viewed. The data of clinical characteristics, complications, and outcomes of these children
were collected and analyzed.
Results: A total of 59 children were enrolled and stratified into three groups: M. pneumoniae
infection alone (nZ 31), M. pneumoniae with Streptococcus pneumoniae coinfection (nZ 9),
and M. pneumoniae with virus coinfection (n Z 19). As compared with children infected with
M. pneumoniae alone, coinfection of children with S. pneumoniae was more likely to occur un-
der the age of 5 years with a longer duration of fever and hospital stay. Furthermore, total
leukocyte count and serum C-reactive protein level were also significantly higher in these chil-
dren (p < 0.01). However, no significant difference in clinical characteristics, complications,
and outcomes was observed between the patients infected with either M. pneumoniae alone
or with virus coinfection.of Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Hsin Street, Kueishan, Taoyuan, Taiwan.
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52 C.-Y. Chiu et al.Conclusion: In children with CAP, the influence on the clinical outcomes of M. pneumoniae
infection may be heavily dependent on the coinfected pathogen. A potential coexistence of
M. pneumoniae infection should be considered in children with features suggesting typical bac-
terial pneumonia.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Mycoplasma pneumoniae is recognized as an important and
frequent cause of community-acquired respiratory illness in
children.1,2 M. pneumoniae causes up to 40% of community-
acquired pneumonia (CAP) in children and as many as 18%
of cases require hospitalization.3 Recent studies showed
that 7e30% of the hospitalized children with CAP had evi-
dence of mixed viralebacterial infections.1,4e8 Coinfection
of M. pneumoniae is not uncommon in children with res-
piratory syndromes. In Taiwan, a prospective study on the
etiology of hospitalized children with CAP demonstrated a
high incidence (41%) of mixed infections and 37% with M.
pneumoniae infection.9 Furthermore, concurrent vir-
alebacterial infection was identified in approximately 60%
of children with M. pneumoniae infection. Although most
M. pneumoniae respiratory infections are mild and self-
limited, the clinical features of coinfection of M. pneu-
moniae are not well described. The aim of this study was to
investigate the impact of bacterial and viral coinfection on
mycoplasmal pneumonia in hospitalized children with CAP.
The manifestations and clinical outcomes in such instances
are also defined and discussed.
Materials and methods
Study population and design
This study was approved by the Institutional Review Board
of Chang Gung Memorial Hospital (No. 102-0401B). Between
August 1, 2001 and July 31, 2002 children coinfected with
M. pneumoniae in a prospective study of the etiology of
CAP at a tertiary pediatric facility Children’s Hospital were
enrolled and retrospectively reviewed. Pneumonia was
defined as the combination of acute respiratory symptoms
and infiltrates on chest radiographic images, which were
interpreted by attending physicians and radiologists. Chil-
dren with M. pneumoniae pneumonia were stratified into
three groups: M. pneumoniae alone, M. pneumoniae coin-
fected with Streptococcus pneumoniae, and M. pneumo-
niae coinfected with virus. The clinical, laboratory, and
radiographic data on admission, as well as complications
and outcomes of these patients, were collected, analyzed,
and compared.
Microbiological diagnostic method
For M. pneumoniae, both acute and convalescent serum
were obtained and measured for antibody response (IgM
and IgG) to M. pneumoniae by enzyme-linkedimmunosorbent assay methods (Savyon, Ashdod, Israel).10
Criteria for acute mycoplasmal infection were either a
single serum showing positive M. pneumoniae-specific IgM
or a seroconversion of IgG.11 S. pneumoniae infection was
defined by a positive result in blood or pleural fluid culture
or the detection of antigens in the pleural fluid by latex
agglutination testing. Acute pneumococcal infection was
also included for patients who had necrotic lung paren-
chyma with a positive urine test for S. pneumoniae (Binax,
Portland, ME, USA).
For viral etiology, viral direct immunofluorescent assay
and cultures were performed using sputum or oropharyn-
geal swabs. A positive result for respiratory syncytial virus
(RSV), adenovirus, parainfluenza 1, 2, and 3, and influenza
A and B was considered significant. Serum specimens were
also examined for these seven respiratory viruses by the
complement fixation method (BioWhittaker, Walkersville,
MD, USA). A 4-fold rise in titer, a titer of at least 1:16, or a
single titer of at least 1:64 (initial titer 1:2) was considered
positive and indicative of acute infection.
Statistical analysis
Statistical analysis was performed using SPSS 10.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). A p value < 0.05 was
considered statistically significant. Parametric data were
compared using analysis of variance (ANOVA) followed by
Bonferroni’s multiple comparison test. When the data were
not normally distributed, or were nonparametric data, the
KruskaleWallis test was used as appropriate. Categorical
data were analyzed using contingency table analysis and
the Chi-square or Fisher’s exact test.
Results
Patients and microbiological diagnosis
Seventy-seven children had evidence of acute M. pneumo-
niae infection (Table 1). In children with paired serum
samples for M. pneumoniae infection, specific IgM was
positive for both occasions in 31 patients and for one
occasion in 25 patients. Another 20 patients were positive
for specific IgM with a single serum sample obtained at the
acute stage. Seroconversion to specific IgG was identified in
only one patient who was negative for IgM. For S. pneu-
moniae infection, two of these 77 patients were positive for
S. pneumonia by blood culture. Of the cases with compli-
cated pleural effusion available for study, eight cases were
positive for S. pneumoniae by latex agglutination test and
eight cases were diagnosed with S. pneumoniae infection
Table 1 Etiologic agents of 77 hospitalized children with
mycoplasmal community-acquired pneumonia (CAP)
Etiologic agent Proportion (%)
Mycoplasma pneumoniae alone 31/77 (40)
Mixed infection 46/77 (60)
Bacteria
Streptococcus pneumoniae 9
Chlamydia sp. 5
S. pneumoniae þ Chlamydia sp. 3
Virus
Adenovirus 5
Influenza A 4
Respiratory syncytial virus (RSV) 3
Parainfluenza-1 2
Parainfluenza-2 1
Parainfluenza-3 1
Adenovirus þ influenza A 1
Adenovirus þ parainfluenza-2 1
RSV þ influenza A 1
Bacteria and virus
Chlamydia sp. þ adenovirus 2
Chlamydia sp. þ adenovirus
þ RSV
1
S. pneumoniae þ adenovirus 2
S. pneumoniae þ RSV 1
S. pneumoniae þ influenza A 1
S. pneumoniae þ influenza B 1
S. pneumoniae þ influenza B
þ adenovirus þ parainflenza-3
1
M.ycobacterium tuberculosis
þ adenovirus
1
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coinfected with two other bacterial pathogens or mixed
viraleother bacterial infections were excluded. A total of
59 children were included in this study and stratified into
three groups: M. pneumoniae alone (n Z 31), M. pneumo-
niae coinfected with S. pneumoniae (n Z 9), and M.
pneumoniae coinfected with virus (n Z 19).
Demographic and clinical characteristics
The mean age of 59 children (19 boys, 40 girls) was 4.8 
0.9 years. All of the patients with S. pneumoniae coinfec-
tion were aged <5 years and most patients with virus co-
infection were female (89%). Fever (100%), cough (100%),
and rhinorrhea (54%) were the three most common symp-
toms. The duration of fever before admission was similar in
the different groups of children. However, the duration of
fever was significantly longer (p < 0.05) in patients coin-
fected with S. pneumoniae. The most common findings on
physical examination were crackles on auscultation.
Tachypnea and decreased breath sounds due to para-
pneumonic effusions were significantly more common in
patients with S. pneumoniae coinfection (p < 0.05). In
contrast, rhinorrhea was significantly higher (p < 0.01) in
patients with virus coinfection. The demographic data and
the clinical characteristics of children enrolled are sum-
marized in Table 2.Laboratory and radiographic findings
No significant difference was noted in terms of differential
white blood cell count, hemoglobin level, or platelet count
between the patients with M. pneumoniae infection alone
and those with mixed S. pneumoniae or virus infection.
However, total leukocyte count and serum C-reactive pro-
tein levels on admission (p < 0.01) were significantly higher
in patients with S. pneumoniae coinfection. Focal retic-
ulonodular patterns (64%) and parahilar peribronchial in-
filtrates (32%) were the two most common chest
radiographic findings. Moreover, lobar consolidation and
pleural effusions were significantly more common in chil-
dren with S. pneumoniae coinfection (p < 0.05).
Complications and outcomes
No significant difference was observed between the patients
infected with M. pneumoniae alone and those coinfected
with virus. Of the nine patients with S. pneumoniae coin-
fection, three with complications (respiratory failure in 2,
thoracostomy in 1) required intensive care. All of these
children with M. pneumoniae pneumonia were treated with
azithromycin manufactured by Pfizer (10 mg/kg of body
weight/day for 3 days). In children coinfected with
S. pneumoniae, the earlier prescribed empirical antibiotics
for S. pneumoniae were continued until the fever had sub-
sided. The duration of hospitalization was significantly
longer (p < 0.01) in patients with M. pneumoniae and
S. pneumoniae coinfection than in those with M. pneumo-
niae infection alone. All children recovered uneventfully.
Comparisons of laboratory findings, radiographic manifes-
tations, complications, and outcomes in various groups of
children withM. pneumoniae infection are shown in Table 3.
Discussion
Mycoplasma pneumoniae plays a significant role as a cause
of CAP in children.1e3 The occurrence of M. pneumonia CAP
throughout the year and seasonal peaks have been reported
in varying periods ranging from the end of summer to win-
ter.12e14 In the present study, infection with M. pneumo-
niae occurred year-round and was similarly common in
autumn. The incidence of mycoplasmal pneumonia was
greatest among children aged 3e7 years, as reported pre-
viously.15 Coinfection with S. pneumonia, however, mostly
occurred in children aged <5 years, which may be
explained partly by a relatively high rate of nasopharyngeal
carriage of S. pneumoniae in preschool-aged children.16
In children, several previous studies indicate that
patients with coinfection accounted for 30e52% of cases of
M. pneumoniae infection.6,17,18 Results from the present
study however showed that the occurrence of coinfection
of M. pneumoniae with other pathogens, either viruses or
other bacteria, was common, at up to 60%. The trend to-
wards high rates of coinfection with M. pneumoniae
infection may be attributed to the higher number of labo-
ratory methods used for pathogens in this study.
Presenting symptoms and radiographic findings in chil-
dren with mycoplasmal pneumonia are nonspecific and
often similar to what is also seen with other various
Table 2 Comparisons of demographic and clinical characteristics of children at enrollment in various etiological groups
Characteristics Mycoplasma
pneumoniae
monoinfection
(n Z 31)
M. pneumoniae with
Streptococcus
pneumoniae
coinfection
(n Z 9)
p M. pneumoniae
with virus
coinfection
(n Z 19)
p
Age (y) 5.6  1.0 3.8  0.7 0.11 4.9  1.0 0.59
<5 12 (39) 9 (100) <0.01 10 (53) 0.39
5 19 (61) 0 (0) 9 (47)
Sex
Male 14 (45) 3 (33) 0.71 2 (11) <0.05
Female 17 (55) 6 (67) 17 (89)
Season
Summer 9 (29) 1 (11) 0.60 1 (5) 0.18
Autumn 15 (48) 5 (56) 10 (53)
Winter 4 (13) 1 (11) 4 (21)
Spring 3 (10) 2 (22) 4 (21)
Symptoms and signs
Fever 31 (100) 9 (100) N/A 19 (100) N/A
Days before admission 5.7  1.0 5.0  1.0 0.76 4.5  0.8 0.25
Days of total 7.6  1.3 11.3  3.5 <0.05 5.6  0.9 0.17
Cough 31 (100) 9 (100) N/A 19 (100) N/A
Rhinorrhea 13 (42) 3 (33) 0.72 16 (84) <0.01
Abdominal pain 5 (16) 4 (44) 0.17 5 (26) 0.47
Tachypnea 1 (3) 4 (44) <0.01 0 (0) >0.99
Chest pain 1 (3) 1 (11) 0.40 0 (0) >0.99
Rales 15 (48) 3 (33) 0.48 11 (58) 0.57
Wheezes 3 (10) 0 (0) >0.99 2 (11) >0.99
Decreased breath sounds 4 (13) 5 (56) <0.05 3 (16) >0.99
Data are no. (%) of patients or mean  standard deviation (SD). The p value is for comparison of patients with M. pneumoniae mon-
oinfection at baseline.
N/A Z Not available.
54 C.-Y. Chiu et al.respiratory viruses, or bacteria.19 In the present study, the
clinical characteristics of tachypnea, and elevated leuko-
cyte count and C-reactive protein level were commonly
seen in children coinfected with S. pneumoniae and M.
pneumoniae. Radiographic findings of lobar consolidation
and parapneumonic effusions were also significantly com-
mon in such instances. However, the association between
these abnormalities and bacterial pneumonia caused by S.
pneumoniae has been well described in children with CAP.20
Apparently, the clinical and radiographic characteristics
may overlap in children with pneumonia either caused by S.
pneumoniae alone or by coinfection with M. pneumoniae
and S. pneumoniae. It is important for clinicians to realize
that a potential coexistence of M. pneumoniae infection
should be considered in children with features suggesting
typical bacterial pneumonia.
Mixed infections with M. pneumoniae are common in
hospitalized children with respiratory syndromes; however,
the clinical implications have not been well
described.6,17,18 In the present study, children coinfected
with virus presented with similar clinical symptoms, labo-
ratory findings, radiologic findings, and clinical outcomes in
comparison with children infected with M. pneumoniae
alone. In contrast, the clinical presentations of children
coinfected with S. pneumoniae were more likely to be se-
vere, and they were likely to have a longer hospital stay.These findings support literature reports indicating that
severe bacterial infection may have either followed or
coincided with M. pneumoniae respiratory infection by
facilitating alterations in local respiratory immunity or
structure and function.21,22 In this study, 20% of children
with pneumonia had three or more microorganisms found
by virus culture or serology methods. Although virus alone
plays a minor role in severe childhood pneumonia that re-
quires hospitalization, viral infection is believed to have a
substantial role of predisposing children to typical bacterial
infections.9 However, it must be emphasized that M.
pneumoniae infection may also precede viral or other
bacterial respiratory infections.22
Pneumonia caused by S. pneumoniae usually accom-
panies intense inflammation followed by parapneumonic
effusion and empyema.20,23,24 In the present study, M.
pneumoniae infection complicated by pleural effusion
resulting in the need for intensive care was significantly
found in children coinfected with S. pneumoniae. The in-
fluence on the clinical outcomes of M. pneumoniae coin-
fection may be heavily dependent on the coinfected
pathogen other than M. pneumoniae itself. A potentially
unfavorable outcome such as necrotizing pneumonitis, lung
abscess, and acute respiratory distress syndrome caused by
M. pneumoniae is, however, occasionally encountered,
attributed to the increase of macrolide-resistant M.
Table 3 Comparisons of laboratory findings, radiographic manifestations, complications, and outcomes in various etiological
groups
Characteristics Mycoplasma
pneumoniae
monoinfection
(n Z 31)
M. pneumoniae with
Streptococcus
pneumoniae
coinfection
(n Z 9)
p M. pneumoniae
with virus
coinfection
(n Z 19)
p
Laboratory findings
Leukocyte count (109/L) 9.122  1.797 15.422  3.707 <0.01 10.605  2.559 0.60
Neutrophils, % 68.7  5.0 77.2  6.3 0.25 69.3  7.2 0.99
Lymphocytes, % 21.0  4.0 12.4  6.8 0.14 21.5  6.0 0.99
Hemoglobin (g/L) 112  4 103  8 0.06 113  4 0.86
Platelet count (1012/L) 26.26  3.74 28.71  10.42 0.82 28.35  3.87 0.78
C-reactive protein (mg/L) 66.5  24.0 296.1  114.3 <0.01 96.7  56.5 0.96
Radiographic findings
Focal reticulonodular pattern 20 (65) 4 (44) 0.44 14 (74) 0.55
Parahilar peribronchial infiltrates 12 (39) 2 (22) 0.45 5 (26) 0.54
Lobar consolidation 8 (26) 6 (67) <0.05 0 (0) <0.05
Pleural effusions 3 (10) 4 (44) <0.05 1 (5) >0.99
Complications and outcomes
Parapneumonic effusions 3 (10) 4 (44) <0.05 1 (5) >0.99
Chest tube placement 0 (0) 1 (11) 0.23 0 (0) N/A
Oxygen hood 13 (42) 4 (44) >0.99 9 (47) 0.78
Intensive management 0 (0) 3 (33) <0.01 0 (0) N/A
Respiratory failure requiring
ventilation
0 (0) 2 (22) <0.05 0 (0) N/A
Uneventful recovery 31 (100) 6 (67) <0.05 19 (100) N/A
Hospital stay (d) 5.1  1.1 11.2  4.2 <0.01 4.3  0.7 0.42
Data are no. (%) of patients or mean  SD. The p value is for comparison of patients with M. pneumoniae monoinfection at baseline.
N/A Z Not available.
Coinfection of Mycoplasma pneumoniae 55pneumoniae in recent years.25e28 Although the respiratory
symptoms caused by M. pneumoniae are usually self-
limiting, therapeutic agents active against mycoplasma
could be a critical component of managing severe cases of
S. pneumoniae and M. pneumoniae coinfection.21,22
In conclusion, a coinfection of M. pneumoniae with
other bacteria or virus is frequently seen in children with
CAP. The influence on the clinical outcomes of M. pneu-
moniae infection may be heavily dependent on the coin-
fected pathogen. In preschool-aged children with CAP who
present with tachypnea and a chest radiograph showing
lobar consolidation, either with or without parapneumonic
effusions, a typical bacterial pathogen, either alone or
coinfected with M. pneumoniae, should be considered.
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